NCT05000294 2026-02-18Atezolizumab Plus Tivozanib in Immunologically Cold Tumor TypesUniversity of FloridaPhase 1/2 Suspended29 enrolled
NCT04400474 2025-06-19CABATENGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed93 enrolled 17 charts